BioCentury | Aug 4, 2014
Clinical News

ATryn: Phase III started

...in patients with hereditary antithrombin deficiency. LFB gained the product through its 2010 acquisition of GTC Biotherapeutics Inc....
BioCentury | May 20, 2013
Company News

Verastem management update

...NASDAQ:VSTM), Cambridge, Mass. Business: Cancer Hired: John Green as CFO, formerly SVP and CFO of GTC Biotherapeutics Inc....
BioCentury | May 14, 2012
Company News

AMAG Pharmaceuticals management update

...Diagnostic Hired: William Heiden as president, CEO and a director, formerly president and CEO of GTC Biotherapeutics Inc....
BioCentury | Dec 13, 2010
Company News

GTC Biotherapeutics, Laboratoire francais deal

...million. The once public company is now a subsidiary of LFB (see BioCentury, Nov. 15). GTC Biotherapeutics Inc....
BioCentury | Nov 15, 2010
Finance

Regulatory milestones

...that day urging the biotech to shelve any defensive actions in response to the offer. GTC Biotherapeutics Inc....
BioCentury | Nov 15, 2010
Company News

GTC Biotherapeutics, Laboratoire francais deal

...and reduce headcount by 50 (46%) to 59 to save cash (see BioCentury, June 21). GTC Biotherapeutics Inc....
BioCentury | Nov 9, 2010
Company News

LFB to acquire GTC

GTC Biotherapeutics Inc. (OTCBB:GTCB) said partner LFB S.A. (Les Ulis, France) agreed to take GTC private for $0.30 per share, or about $21 million. The price is a 7% premium to GTC's close of $0.28...
BioCentury | Oct 25, 2010
Company News

GTC Biotherapeutics, Laboratoire francais deal

...and reduce headcount by 50 (46%) to 59 to save cash (see BioCentury, June 21). GTC Biotherapeutics Inc....
BioCentury | Sep 23, 2010
Cover Story

Combining antibodies to eliminate NHL

...immune responses against cancer cells," said Yann Echelard, VP of corporate and technology development at GTC Biotherapeutics Inc....
...Francisco, Calif. Fresenius SE (Xetra:FRE), Bad Homburg, Germany Genentech Inc. , South San Francisco, Calif. GTC Biotherapeutics Inc....
BioCentury | Jul 19, 2010
Company News

GTC Biotherapeutics, Lundbeck deal

...to save cash and focus on improving the profitability of ATryn (see BioCentury, June 21). GTC Biotherapeutics Inc....
Items per page:
1 - 10 of 269
BioCentury | Aug 4, 2014
Clinical News

ATryn: Phase III started

...in patients with hereditary antithrombin deficiency. LFB gained the product through its 2010 acquisition of GTC Biotherapeutics Inc....
BioCentury | May 20, 2013
Company News

Verastem management update

...NASDAQ:VSTM), Cambridge, Mass. Business: Cancer Hired: John Green as CFO, formerly SVP and CFO of GTC Biotherapeutics Inc....
BioCentury | May 14, 2012
Company News

AMAG Pharmaceuticals management update

...Diagnostic Hired: William Heiden as president, CEO and a director, formerly president and CEO of GTC Biotherapeutics Inc....
BioCentury | Dec 13, 2010
Company News

GTC Biotherapeutics, Laboratoire francais deal

...million. The once public company is now a subsidiary of LFB (see BioCentury, Nov. 15). GTC Biotherapeutics Inc....
BioCentury | Nov 15, 2010
Finance

Regulatory milestones

...that day urging the biotech to shelve any defensive actions in response to the offer. GTC Biotherapeutics Inc....
BioCentury | Nov 15, 2010
Company News

GTC Biotherapeutics, Laboratoire francais deal

...and reduce headcount by 50 (46%) to 59 to save cash (see BioCentury, June 21). GTC Biotherapeutics Inc....
BioCentury | Nov 9, 2010
Company News

LFB to acquire GTC

GTC Biotherapeutics Inc. (OTCBB:GTCB) said partner LFB S.A. (Les Ulis, France) agreed to take GTC private for $0.30 per share, or about $21 million. The price is a 7% premium to GTC's close of $0.28...
BioCentury | Oct 25, 2010
Company News

GTC Biotherapeutics, Laboratoire francais deal

...and reduce headcount by 50 (46%) to 59 to save cash (see BioCentury, June 21). GTC Biotherapeutics Inc....
BioCentury | Sep 23, 2010
Cover Story

Combining antibodies to eliminate NHL

...immune responses against cancer cells," said Yann Echelard, VP of corporate and technology development at GTC Biotherapeutics Inc....
...Francisco, Calif. Fresenius SE (Xetra:FRE), Bad Homburg, Germany Genentech Inc. , South San Francisco, Calif. GTC Biotherapeutics Inc....
BioCentury | Jul 19, 2010
Company News

GTC Biotherapeutics, Lundbeck deal

...to save cash and focus on improving the profitability of ATryn (see BioCentury, June 21). GTC Biotherapeutics Inc....
Items per page:
1 - 10 of 269